Latest Rheumatology Stories
New webinar will focus on scientific and process improvements that advance Rheumatoid Arthritis (RA) drug development.
In a new study in patients with osteoarthritis (OA) of the knee, at 12 months, total femorotibial cartilage thickness loss was reduced in sprifermin (recombinant human fibroblast growth factor 18)-treated knees compared to placebo-treated knees, with effects being significant in the lateral femorotibial compartment but not in the central femorotibial compartment.
In May, over three dozen nonprofits around the world, along with thousands of patients, supporters, practitioners, and researchers, will unite under one ‘virtual roof’ to participate in the
Arthritis Foundation Raises Funds for a Cure in the San Francisco Walk to Cure Arthritis SAN FRANCISCO, April 16, 2014 /PRNewswire/ -- Help find a cure by participating in and fundraising
NORWALK, Conn., April 16, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network,
Achieve is conducting a randomized, active and placebo-controlled study to evaluate the efficacy and safety of an experimental drug for preventing flares and reducing serum uric acid in
The latest in Osteoporosis Risk Assessment and Treatment was discussed with Primary Care practitioners at the 8th Annual Spring CME (Continuing Medical Education) Conference held by the Continuing
Arthritis Foundation Raises Funds for a Cure in the Cincinnati Walk to Cure Arthritis CINCINNATI, April 15, 2014 /PRNewswire/ -- Help find a cure by participating in and fundraising for the
FORT WORTH, Texas, April 14, 2014 /PRNewswire/ -- ReCept announces that it is among a select group of specialty pharmacies selected by Celgene to distribute Otezla® (apremilast), a new
Estimated Expenditure Tops $10 Billion; Afflicted Patients among Bottom 20% for Quality of Life SAN JOSE, Calif., April 14, 2014 /PRNewswire/ -- SI-BONE, Inc.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.